ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 75 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $3,569,000 | +27.4% | 89,778 | +11.3% | 0.00% | +50.0% |
Q4 2018 | $2,802,000 | -58.8% | 80,662 | -51.0% | 0.00% | 0.0% |
Q3 2018 | $6,804,000 | +107.1% | 164,560 | +84.1% | 0.00% | 0.0% |
Q2 2018 | $3,285,000 | +14.1% | 89,381 | +21.1% | 0.00% | 0.0% |
Q1 2018 | $2,879,000 | +156.6% | 73,832 | +19.1% | 0.00% | +100.0% |
Q4 2017 | $1,122,000 | +6.2% | 61,978 | -2.9% | 0.00% | 0.0% |
Q3 2017 | $1,056,000 | +11.2% | 63,812 | -6.0% | 0.00% | 0.0% |
Q2 2017 | $950,000 | -26.9% | 67,892 | +7.4% | 0.00% | 0.0% |
Q1 2017 | $1,299,000 | +34.2% | 63,231 | -7.3% | 0.00% | 0.0% |
Q4 2016 | $968,000 | -34.8% | 68,179 | -1.7% | 0.00% | 0.0% |
Q3 2016 | $1,484,000 | -7.9% | 69,364 | -3.2% | 0.00% | 0.0% |
Q2 2016 | $1,612,000 | +63.0% | 71,630 | +37.9% | 0.00% | 0.0% |
Q1 2016 | $989,000 | -49.3% | 51,947 | -29.6% | 0.00% | 0.0% |
Q4 2015 | $1,949,000 | -17.6% | 73,782 | -1.9% | 0.00% | -50.0% |
Q3 2015 | $2,366,000 | -31.3% | 75,242 | +15.3% | 0.00% | 0.0% |
Q2 2015 | $3,442,000 | +333.0% | 65,245 | +241.2% | 0.00% | +100.0% |
Q1 2015 | $795,000 | +932.5% | 19,121 | +562.5% | 0.00% | – |
Q4 2014 | $77,000 | – | 2,886 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 800,000 | $11,656,000 | 5.38% |
Consonance Capital Management LP | 5,238,218 | $76,321,000 | 4.57% |
BRIDGER MANAGEMENT, LLC | 1,785,784 | $26,019,000 | 2.41% |
Trellus Management Company, LLC | 150,000 | $2,186,000 | 2.37% |
MAVERICK CAPITAL LTD | 6,754,102 | $98,407,000 | 2.07% |
Redmile Group, LLC | 6,843,370 | $99,708,000 | 1.84% |
Baupost Group | 9,922,030 | $144,564,000 | 1.80% |
Camber Capital Management LP | 1,400,000 | $20,398,000 | 1.17% |
Pinz Capital Management, LP | 161,100 | $2,347,000 | 1.08% |
Artal Group S.A. | 2,500,000 | $36,425,000 | 1.02% |